Royan Institute and Sina Hospital MS Research Center to Convene Scientific Symposium on Preclinical Studies of Multiple Sclerosis

A scientific symposium dedicated to preclinical research in multiple sclerosis (MS), jointly organized by Royan Institute and the Multiple Sclerosis Research Center of Sina Hospital, affiliated with Tehran University of Medical Sciences, will be held on December 31, 2026, in Tehran, Iran. The symposium will bring together clinicians and researchers to examine emerging experimental models, methodological advances, and translational research strategies aimed at advancing the understanding and treatment of MS.

According to the Public Relations Department of Royan Institute, the symposium, entitled "Preclinical Studies of Multiple Sclerosis," will take place on Thursday, December 31, 2026 (10 Dey 1405), from 8:00 a.m. to 2:00 p.m. at the Multiple Sclerosis Research Center of Sina Hospital in Tehran. The event is being organized in collaboration with Royan Institute and the Multiple Sclerosis Research Center of Sina Hospital, Tehran University of Medical Sciences.

Held on the occasion of the anniversary of the passing of the late Dr. Saeed Kazemi Ashtiani, founder of Royan Institute, the symposium also reflects the Institute's longstanding commitment to honoring his scientific legacy through the organization of academic gatherings and research-oriented events. It aims to foster meaningful interaction and strengthen scientific collaboration between clinicians and researchers working in the field of multiple sclerosis.

Dr. Mohammad Javan, from Royan Institute and Tarbiat Modares University, and Dr. Sajjad Sahabnegah, from the Multiple Sclerosis Research Center of Sina Hospital, Tehran University of Medical Sciences, will serve as the scientific chairs of the symposium. Dr. Alireza Alizadeh Moghadam Masouleh, from Royan Institute, will undertake the roles of course director and executive secretary.

Advancing Preclinical Research in Multiple Sclerosis

Preclinical studies constitute a fundamental stage in the development of drugs and therapeutic interventions. Conducted prior to human clinical investigations, these studies provide a framework for evaluating therapeutic efficacy, safety, and the reproducibility of research findings. Rigorous study design and implementation can substantially contribute to improving the quality of subsequent clinical research, mitigating potential risks, and optimizing the allocation of human and financial resources.

Given the complex pathophysiology of multiple sclerosis and the need for a deeper understanding of the mechanisms underlying its onset and progression, the development of robust preclinical research strategies is of particular importance. Such efforts increasingly rely on multidisciplinary approaches and the integration of computational, cellular, and animal models to investigate disease mechanisms and assess potential therapeutic interventions.

Scientific Scope and Key Topics

The symposium will address a broad range of scientific and methodological topics, including the relationship between preclinical and clinical MS research, future directions in the field, disease etiology, research requirements for myelin repair and remyelination, fundamental principles of preclinical drug study design, and medicinal chemistry.

Particular attention will be given to computational models and in vitro experimental approaches as strategies for reducing reliance on laboratory animals. The scientific program will also examine the advantages and limitations of different animal models, including mice, rats, and zebrafish, alongside statistical considerations essential to the design and analysis of preclinical investigations.

Royan Institute's Zebrafish Model of Multiple Sclerosis: A New Research Opportunity

A highlight of the symposium will be the presentation of the zebrafish model of multiple sclerosis developed at Royan Institute's Zebrafish Laboratory. Alongside established experimental approaches, this model may offer additional opportunities to investigate disease-associated mechanisms and evaluate potential therapeutic strategies.

The presentation will include findings from collaborative research conducted by the Multiple Sclerosis Research Center of Sina Hospital, Tehran University of Medical Sciences, and Royan Institute, focusing on the development of zebrafish-based approaches for MS research. This collaborative research initiative has been conducted under the scientific leadership of Dr. Mohammad Ali Sahraian and Dr. Hossein Baharvand.

Three-Day Practical Workshop on Zebrafish Modeling

Complementing the scientific symposium, a three-day hands-on workshop entitled "Introduction to Zebrafish and Its Application in Modeling Human Diseases," with a particular emphasis on multiple sclerosis, will be held from January 6 to 8, 2027 (16–18 Dey 1405), at Royan Institute's Central Zebrafish Laboratory in Tehran.

The workshop is intended to provide participants with practical exposure to zebrafish-based research methodologies and their application in modeling human diseases.

Target Audience and Registration

The symposium and associated workshop are intended for specialists, researchers, and students in medicine, neuroscience, pharmaceutical sciences, veterinary medicine, biology, genetics, biostatistics, physiology, bioinformatics, fisheries, and aquatic sciences.

For registration and further information, interested participants are invited to visit the Royan Institute Education Deputy's official website.

For further inquiries:

  • +98 21 2356 2451

  • +98 21 2356 2323

  • +98 903 111 8415

Venue: Multiple Sclerosis Research Center, Sina Hospital, Tehran, Iran

Symposium Date: December 31, 2026 | 8:00 a.m.–2:00 p.m.

Practical Workshop: January 6–8, 2027 | Royan Institute, Tehran, Iran

Publish date: 2026/11/14
goup